Pontifax Venture Capital
Overview
Pontifax Venture Capital is a Herzeliya-based venture capital firm specializing in life sciences investments. The firm focuses on transformative healthcare technologies across all development stages, managing over $1.2 billion in assets. Pontifax's portfolio includes approximately 100 companies developing breakthrough solutions to address substantial unmet needs in the healthcare sector. The firm is deeply involved in its portfolio management, taking a hands-on approach to nurture start-ups to maturity. Pontifax's investment strategy encompasses various stages, from early-stage ventures to growth and late-stage investments. The firm is actively involved in its portfolio companies, providing hands-on guidance, networking, and experience to maximize the potential for success. Pontifax's expertise spans multiple sectors within the life sciences industry, including biotechnology, medical devices, pharmaceuticals, and healthcare services. With a strong track record of successful investments, Pontifax has established itself as a prominent player in the venture capital landscape, particularly within the life sciences sector. The firm's commitment to identifying and nurturing innovative healthcare technologies has contributed to the growth and success of numerous start-ups, solidifying its reputation as a leading venture capital firm in the industry.
Investment Focus
- Innovative life sciences technologies
- Strong management teams
- Potential for significant impact in healthcare
- Innovative healthcare technologies
- Scalable business models
- Potential for significant market impact
Portfolio Companies
Get the full list of 54,000+ investors
Pontifax Venture Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Pontifax Venture Capital
What sectors does Pontifax Venture Capital invest in?
Pontifax Venture Capital invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Herzliyya, Israel. Pontifax Venture Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Pontifax Venture Capital invest at?
Pontifax Venture Capital backs companies at Pre-Seed, Seed, Early Stage, Series A, Series B and Growth.
Which regions does Pontifax Venture Capital invest in?
Pontifax Venture Capital invests across United States, Canada, Middle East, Israel, Western Europe and Northern Europe.
Who are the partners at Pontifax Venture Capital?
Team members listed for Pontifax Venture Capital include Alon Nussbaum (Vice President Strategic Initiatives) and Lina Kaminski (Principal).
What companies has Pontifax Venture Capital invested in?
Pontifax Venture Capital's portfolio includes AgomAb Therapeutics, Prevail Therapeutics, CureMetrix, Keros Therapeutics, Amolyt Pharma, Theseus Pharmaceuticals, Precirix and BioCatch.
How do I contact Pontifax Venture Capital?
Pontifax Venture Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
